Prognostic Value of MCM2 Immunoreactivity in Stage T1 Transitional Cell Carcinoma of the Bladder

2003 ◽  
Vol 43 (2) ◽  
pp. 138-145 ◽  
Author(s):  
Stefan Krüger ◽  
Christoph Thorns ◽  
Winfried Stöcker ◽  
Ewald Müller-Kunert ◽  
Andreas Böhle ◽  
...  
1993 ◽  
Vol 60 (2) ◽  
pp. 152-157
Author(s):  
D. Grassi ◽  
M. De Siati ◽  
N. Franzolin

During this last decade, flow cytometry (FCM) has been widely investigated and employed in assessing the DNA content of bladder tumours. The prognostic value of FCM is recognised by the majority of investigators, above all when it concerns superficial transitional cell carcinoma of the bladder. The determination of ploidy and the degree of aneuploidy seem to offer valuable prognostic information. The Authors have reviewed Literature on this subject, identifying three different categories of studies that analyse the relation of FCM to cytohystological characterisation, to the clinical behaviour of the tumours and to the patients’ survival.


2007 ◽  
Vol 33 (2) ◽  
pp. 161-166 ◽  
Author(s):  
Alberto A. Antunes ◽  
Luciano J. Nesrallah ◽  
Marcos F. Dall'Oglio ◽  
Alexandre Crippa ◽  
Adriano J. Nesrallah ◽  
...  

2001 ◽  
Vol 29 (6) ◽  
pp. 377-387 ◽  
Author(s):  
Paolo Gontero ◽  
Alessandro Tizzani ◽  
Gordon H. Muir ◽  
Emanuele Caldarera ◽  
Michele Pavone Macaluso

Sign in / Sign up

Export Citation Format

Share Document